| American Scientific Research

Editor Name: Raghda Fouda

Country: USA

University: University of California Irvine

BIOGRAPHY

Raghda Fouda, a specialist in pathology and laboratory medicine who graduated from the school of medicine, Cairo University, and completed a Ph.D. degree in clinical pathology and laboratory medicine with diagnostic immunohematology and transfusion medicine as a major. She have ten-year laboratory experience during which she developed skills in a wide range of laboratory techniques including bone marrow pathology, molecular studies, in situ hybridization and Flow cytometry as well as blood banking and stem cell transplantation. She has interest in immunology and hematology research as well as regenerative medicine and stem cell research. She have a number of publication in the field of immune-hematology, transfusion medicine, hematological disorders, inflammation and obesity and their effect on number of body system with high concern on vascular endothelium and cardiologic complication and recently led a research team concerned with COVID19 pathogenesis and immune response. Currently, she have joined Stem Cell Research Center in University of California Irvine, working on the development of a humanized rat model for the cause of treatment retinal degeneration using stem cell therapy.

RESEARCH INTEREST:

Immunology and hematology research as well as regenerative medicine and stem cell research.

PUBLICATION:

1. Single Cell Sequencing unraveling genetic basis of shared immunologic switch between severe COVID-19 and obesityOctober 2020Obesity Medicine

2. The potential use of ABO blood group system for risk stratification of COVID-19October 2020Medical Hypotheses

3. COVID-19 during pregnancy should we really worry from vertical transmission or rather from fetal hypoxia and placental insufficiency? A systematic review and meta -analysis .Maternal and fetal medicineSeptember 2020

4. A multicenter consensus: A role of furin in the endothelial tropism in obese patients with COVID-19 infection June 2020.

5. Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19. May 2020.

6. Impact of storage, leucofiltration and ascorbic acid fortification on red cell-derived microparticles in stored packed RBCs. A Flow cytometric and Procoagulant Study. Journal of Applied Hematology. Accepted February 2020

7. Right ventricular functions in subphenotypes of Sickle cell Disease. Journal of the Saudi Heart Association. September 2019.

8. A case report “Chronic eosinophilic leukemia: Behçet's disease mimic “published Open Journal of Clinical and Medical Case Reports April 2018

CONFERENCE ATTEND:

Oral presentation at the European Hematology Association “Highlights of Past EHA-HOPE Cairo” September 2018 under the title of “Impact of storage, leucofiltration, ascorbic acid fortification on red cell-derived microparticles in stored packed RBCs”

Speaker and organizer in Myeloma defining event workshop, Cairo University, April 2018.

Speaker in the first joint KasrAlainy hematology meeting “bleeding disorder are never simple”, April 2018

Speaker in chromosomal breakage and related disorders workshop, Cairo University in collaboration with ECPT. December 2016

International conference of the Egyptian society of hematology and research (ESHR), October 2017

Speaker in the 18th international thalassemia day, May 2017